APA (7th ed.) Citation

Price, T., Burge, M., Chantrill, L., Chua, Y., Horvath, L., McLachlan, S., . . . Tancock, G. (2020). 107P Safety and efficacy of trifluridine/tipiracil (FTD/TPI) in previously treated metastatic colorectal cancer (mCRC): Results from the Australian cohort of the phase IIIb, international, open-label, early-access PRECONNECT study. Annals of Oncology, 31, S1283. https://doi.org/10.1016/j.annonc.2020.10.127

Chicago Style (17th ed.) Citation

Price, T.J, et al. "107P Safety and Efficacy of Trifluridine/tipiracil (FTD/TPI) in Previously Treated Metastatic Colorectal Cancer (mCRC): Results from the Australian Cohort of the Phase IIIb, International, Open-label, Early-access PRECONNECT Study." Annals of Oncology 31 (2020): S1283. https://doi.org/10.1016/j.annonc.2020.10.127.

MLA (9th ed.) Citation

Price, T.J, et al. "107P Safety and Efficacy of Trifluridine/tipiracil (FTD/TPI) in Previously Treated Metastatic Colorectal Cancer (mCRC): Results from the Australian Cohort of the Phase IIIb, International, Open-label, Early-access PRECONNECT Study." Annals of Oncology, vol. 31, 2020, p. S1283, https://doi.org/10.1016/j.annonc.2020.10.127.